An official website of the United States government
          Here’s how you know
        Here’s how you know**Official websites use .gov**A
              **.gov** website belongs to an official government
              organization in the United States.
        **Secure .gov websites use HTTPS**A
              **lock** (
              Locked padlock icon) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
 Top Utility Nav
        
        
        Asian-Language Resources
        
        Portal en español


Site search Mega Menu
  

        

        Home
                  Health Topics
                                      
    
  Health Topics

    Arthritis and Rheumatic Diseases
          
    Muscle and Bone Diseases
          
    Skin Diseases
          
    All Diseases and Conditions
          
    Publication Catalog
                  Grants & Funding
                                      
    
  Grants & Funding

    Current Funding Opportunities
          
    Supported Scientific Programs
          
    NIAMS-Supported Programs
          
    Applying for a Grant
          
    NIH Policies and Guidance
          
    Peer Review and Grants Administration Resources
          
    Types of Funding Mechanisms (Activity Codes)
                  Labs @ NIAMS
                                      
    
  Labs @ NIAMS

    NIAMS Labs and Core Facilities
          
    Research Faculty
          
    Research Areas
          
    NIAMS Scientific Advances
          
    Training and Career Development
                  Clinical Trials
                                      
    
  Clinical Trials
      
            For Principal Investigators

    Clinical Trial Policies, Guidelines, and Templates
          
    Conducting Clinical Trials
          
    Register with ClinicalTrials.gov

For Patients

What is a Clinical Trial?
	Clinical Trials at NIAMS
	Clinical Trials in the Spotlight
                  News & Events
                                      
    
  Newsroom

    All NIAMS News
          
    NIAMS Newsletters
          
    Meetings & Events
                  About NIAMS
                                      
    
  About NIAMS

    Director's Page
          
    NIAMS Organization
          
    Strategic Plan Fiscal Years 2020-2024
          
    Staff Directory
          
    NIAMS Budget
          
    Partnerships
          
    Contact NIAMS
                  Community Outreach
                                      
    
  Community Outreach

    Bone Health
          
    Joint Health
          
    Muscle, Tendon, and Ligament Health
          
    Skin Health
          
    Health Information For Kids And Young Adults
          
    Health Information For Older Adults/Seniors
          
    Printable Materials for Community Events
          
    Resources in Other Languages
          
    Annual Health Observances
          
    Social Media Resources Breadcrumb
    Home
          Grants & Funding: The NIAMS Extramural Program
          NIAMS-Supported Research Programs
          NIAMS HIV/AIDS Program








NIAMS HIV/AIDS Program FacebookEmailPrintFacebookEmail     
    Image
              HIV cells image


Overview

While the success of antiretroviral therapies continues to improve the life expectancy of people living with HIV/AIDS (PLWHA), both aging and HIV-treatment are associated with the early appearance or greater risk of comorbidities that affect the musculoskeletal system and skin. In order to address the mechanisms underlying these changes and understand the pathogenesis of these comorbidities in PLWHA, NIAMS is committed to promoting research efforts to this field of research within the mission areas of systemic rheumatic, musculoskeletal, and skin diseases.

NIAMS supports and encourages observational, translational, and basic/pre-clinical research focused on how the presence or treatment of HIV/AIDS impacts various disease areas. Below are examples of HIV/AIDS-associated comorbidities that are within the NIAMS mission:

Musculoskeletal pain
	Muscle diseases (e.g., sarcopenia, cachexia, muscular dystrophy)
	Cartilage degeneration (e.g., osteoarthritis)
	Bone diseases (e.g., osteoporosis, osteopenia) or bone fracture
	Arthritis and other rheumatic diseases (e.g., reactive arthritis, psoriatic arthritis, septic arthritis)
	Dermatological manifestationNIAMS is supportive of projects utilizing existing HIV/AIDS cohorts and repositories or leveraging resources from clinical research studies to conduct ancillary studies that investigate the effects of HIV infection and/or antiretroviral therapy on diseases and conditions within the NIAMS mission. Areas of interest include, but are not limited to, the following:

Delineation of the impact of viral and/or host factors or interaction of these factors, or anti-retroviral therapy (ART) in people living with HIV (PLWH) on accelerating or worsening or early onset of comorbidities.
	Studies on the prevalence and risk assessment and management of HIV/AIDS-associated comorbidities in PLWH.
	Identification of etiological targets or biomarkers along with mechanistic action for diagnosis or preclinical candidate therapeutic evaluation/development.Current Funding Opportunities

NOT-AR-23-004: Notice of Special Interest: Promoting research opportunities on HIV/AIDS in NIAMS

	PA-20-185: NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
		PA-20-195: NIH Exploratory /Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)
		PAR-23-025: Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed)
		PAR-23-026: Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed)
		PAR-21-053: Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
		PA-20-272: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
	PAR-21-068: Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)
	PAR-21-069: Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)
	PAR-21-246: HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Institutions (R21 Clinical Trial Optional)Applications submitted to NIAMS should meet the NIH HIV/AIDS Research Priorities and Guidelines as indicated in NOT-OD-20-018: NIH HIV/AIDS Research Priorities and Guidelines for Determining AIDS Funding.

Additional HIV/AIDS Research Resources

Strategic Plan for Trans-NIH Plan for HIV-Related Research
	NIH HIV/AIDS Online Resources
	NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding
	NIH Workshop on HIV-Associated Comorbidites, Co-infections, & Complications: The workshop aimed to foster a better understanding of HIV-associated comorbidities, coinfections, and complications as well as identify scientific opportunities. Following the meeting, working groups continue to identify gaps, challenges and opportunities within the various disease areas. View the workshop summary for more information.For additional questions, please contact the NIAMS HIV/AIDS Coordinator, Dr. Heiyoung Park.


Last Updated: November 2022


Back to Top
 About NIAMS
                    Clinical Trials
                    Grants & Funding
                    Health Topics
                    Labs @ NIAMS
              News Room
                    NIAMS Multimedia Library
                    Disclaimer
                    FOIA
                    Contact us
              Privacy Statement
                    Accessibility
                    HHS Vulnerability Disclosure
                    Social Media Moderation Policy
                    NIAMS Archives
        Subscribe to Our E-Newsletters
            Click the button to see different options to sign up for newsletters.
            Click Here to Subscribe
          Follow us on
  
  About NIH
                  Accessibility Support
            FOIA requests
                  No FEAR Act data
            Office of the Inspector General
                  Performance reports
            Privacy Policy